Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis | |
Wang Y.; Qu X.; Shen H.-C.; Wang K.; Liu Q.; Du J.-J. | |
刊名 | Asian Pacific Journal of Cancer Prevention |
2015 | |
卷号 | 16期号:11页码:4759-4768 |
关键词 | Anti-EGFR agents Hung cancer K-ras mutation Loss of PTEN PIK3CA mutation |
DOI | 10.7314/APJCP.2015.16.11.4759 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4789207 |
专题 | 山东大学 |
作者单位 | 1.Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, China 2.Institute |
推荐引用方式 GB/T 7714 | Wang Y.,Qu X.,Shen H.-C.,et al. Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis[J]. Asian Pacific Journal of Cancer Prevention,2015,16(11):4759-4768. |
APA | Wang Y.,Qu X.,Shen H.-C.,Wang K.,Liu Q.,&Du J.-J..(2015).Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis.Asian Pacific Journal of Cancer Prevention,16(11),4759-4768. |
MLA | Wang Y.,et al."Predictive and prognostic biomarkers for patients treated with anti-EGFR agents in lung cancer: A systemic review and meta-analysis".Asian Pacific Journal of Cancer Prevention 16.11(2015):4759-4768. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论